Domestic
On August 31, 2026, President Donald Trump announced voluntary drug pricing agreements with nine pharmaceutical companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio Pharma, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. These companies agreed…
Impact: The United States — White House hosted the announcement and promoted the deals as delivering savings. It also launched the TrumpRx website and touted declining drug prices, though experts question the attribution.
Aug 18, 2026 · 37 articles